Moxifloxacin-gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation

Archives of Pharmacal Research

Volumn 34, Issue 10, 2011, Pages 1663-1678

  El Laithy, Hanan M ^a   Nesseem, Demiana I ^b   El Adly, Amira A ^c   Shoukry, Meriana ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

^c Cairo University   (Egypt)

Author keywords

Gelrite ; In situ gelling systems; Moxifloxacin; Ocular delivery; Photodynamic therapy

Indexed keywords

GELRITE; HEMATOPORPHYRIN; MOXIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG SCREENING; ESCHERICHIA COLI; INTERMETHOD COMPARISON; KERATITIS; LIGHT EMITTING DIODE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OSMOLALITY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; RABBIT; STAPHYLOCOCCUS;

ADHESIVENESS; ANIMALS; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; AREA UNDER CURVE; AZA COMPOUNDS; BACTERIAL INFECTIONS; BACTERIAL LOAD; CHEMISTRY, PHARMACEUTICAL; CORNEA; CORNEAL DISEASES; ESCHERICHIA COLI; EXCIPIENTS; GELS; KERATITIS; LIGHT; MALE; MICROBIAL SENSITIVITY TESTS; MUCOUS MEMBRANE; OPHTHALMIC SOLUTIONS; OSMOTIC PRESSURE; PHOTOCHEMOTHERAPY; POLYSACCHARIDES, BACTERIAL; QUINOLINES; RABBITS; REFERENCE STANDARDS; SPECTROMETRY, FLUORESCENCE; STAPHYLOCOCCUS AUREUS; VISCOSITY;

EID: 82055172156     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1011-5     Document Type: Article

References (97)

1. Y. Ali K. Lehmussaari 2006 Industrial perspective in ocular drug delivery Adv. Drug Deliv. Rev. 58 1258 1268 17079049 1:CAS:528:DC%2BD28Xht1CnsL3L 10.1016/j.addr.2006.07.022
2. R. S. Al-Kassas M. M. El-Khatib 2009 Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers Drug Deliv. 16 145 152 19514974 1:CAS:528:DC%2BD1MXmtV2gu78%3D 10.1080/10717540802689008
3. G. P. Andrews T. P. Laverty D. S. Jones 2009 Mucoadhesive polymeric platforms for controlled drug delivery Eur. J. Pharm. Biopharm. 71 505 518 18984051 1:CAS:528:DC%2BD1MXisFWgt7c%3D 10.1016/j.ejpb.2008.09.028
4. S. S. Anumolu Y. Singh D. Gao S. Stein P. J. Sinko 2009 Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response J. Control. Release 137 152 159 19341773 1:CAS:528:DC%2BD1MXmvVOktb0%3D 10.1016/j.jconrel.2009.03.016
5. A. A. Badawi H. M. El-Laithy R. K. El Qidra H. El Mofty M. El dally 2008 Chitosan based nanocarriers for indomethacin ocular delivery Arch. Pharm. Res. 31 1040 1049 18787795 1:CAS:528:DC%2BD1cXhtVClurrE 10.1007/s12272-001-1266-6
6. I. B. Bajaj S. A. Survase P. S. Saudagar R. S. Singhal 2007 Gellan gum: fermentative production, downstream processing and applications Food Technol. Biotechnol. 45 341 354 1:CAS:528:DC%2BD1cXkslOhs7Y%3D (Pubitemid 351377915)
7. J. Balasubramaniam J. K. Pandit 2003 Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride Drug Deliv. 10 185 191 12944139 1:CAS:528:DC%2BD3sXmslCls7o%3D 10.1080/713840402 (Pubitemid 36993370)
8. G. Bertoloni F. M. Lauro G. Cortella M. Merchat 2000 Photosensitizing activity of hematoporphyrin on Staphylococcus aureus cells Biochim. Biophys. Acta 1475 169 174 10832032 1:CAS:528:DC%2BD3cXjs1Cit7c%3D (Pubitemid 30314630)
9. G. Borchard H. L. Lueen A. G. de Boer J. C. Verhoef C.-M. Lehr H. E. Junginger 1996 The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro J. Control. Release 39 131 138 1:CAS:528:DyaK28Xjt1yktLc%3D 10.1016/0168-3659(95)00146-8 (Pubitemid 26194212)
10. C. L. Bourlais L. Acar H. Zia P. A. Sado T. Needham R. Leverge 1998 Ophthalmic drug delivery systems-recent advances Prog. Retin. Eye Res. 17 33 58 9537794 1:STN:280:DyaK1c7nsl2jsg%3D%3D 10.1016/S1350-9462(97)00002-5 (Pubitemid 28040752)
11. J. Carlfors K. Edsman R. Petersson K. Jörnving 1998 Rheological evaluation of Gelrite in situ gels for ophthalmic use Eur. J. Pharm. Sci. 6 113 119 9795027 1:CAS:528:DyaK1cXhsFejt78%3D 10.1016/S0928-0987(97)00074-2 (Pubitemid 28164281)
12. A. P. Castano T. N. Demidova M. R. Hamblin 2004 Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization Photodiagnosis Photodyn. Ther. 1 279 293 1:CAS:528: DC%2BD2MXks1Wls7s%3D 10.1016/S1572-1000(05)00007-4 (Pubitemid 40460316)
13. N. A. Charoo K. Kohli A. Ali 2003 Preparation of in situforming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies J. Pharm. Sci. 92 407 413 12532390 1:CAS:528:DC%2BD3sXhtFantL0%3D 10.1002/jps.10290 (Pubitemid 36169313)
14. M. Constantinou M. Daniell G. R. Snibson H. T. Vu H. R. Taylor 2007 Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial Ophthalmology 114 1622 1629 17822972 10.1016/j.ophtha.2006.12.011 (Pubitemid 47332654)
15. T. Dai G. P. Tegos T. Zhiyentayev E. Mylonakis M. R. Hamblin 2010 Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model Lasers Surg. Med. 42 38 44 20077489 10.1002/lsm.20887
16. J. M. de Almeida L. H. Theodoro A. F. Bosco M. J. Nagata S. Bonfante V. G. Garcia 2008 Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes J. Periodontol. 79 2156 2165 18980525 10.1902/jop.2008.080103
17. P. B. Deasy K. J. Quigley 1991 Rheological evaluation of deacetylated gellan gum (Gelrite) for pharmaceutical use Int. J. Pharm. 73 117 123 1:CAS:528:DyaK3MXkvF2itro%3D 10.1016/0378-5173(91)90034-L
18. T. N. Demidova F. Gad T. Zahra K. P. Francis M. R. Hamblin 2005 Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria J. Photochem. Photobiol. B 81 15 25 16040251 1:CAS:528:DC%2BD2MXhtVart7bN 10.1016/j.jphotobiol.2005.05.007 (Pubitemid 41435267)
19. R. F. Donnelly P. A. McCarron M. M. Tunney 2008 Antifungal photodynamic therapy Microbiol. Res. 163 1 12 18037279 1:CAS:528:DC%2BD1cXivVSjtLg%3D 10.1016/j.micres.2007.08.001 (Pubitemid 350251183)
20. A. A. El-Adly 2008 Photoactive anionic porphyrin derivative against Gram-positive and Gram-negative bacteria J. Appl. Sci. Res. 4 1817 1821 1:CAS:528:DC%2BD1MXjsFOitrY%3D
21. A. H. El-Kamel 2002 In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate Int. J. Pharm. 241 47 55 12086720 1:CAS:528:DC%2BD38XkslShurY%3D 10.1016/S0378-5173(02)00234-X (Pubitemid 34667065)
22. L. A. Fernandes J. M. de Almeida L. H. Theodoro A. F. Bosco M. J. Nagata T. M. Martins T. Okamoto V. G. Garcia 2009 Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats J. Clin. Periodontol. 36 219 228 19236534 1:CAS:528:DC%2BD1MXjslKgtL0%3D 10.1111/j.1600-051X.2008. 01355.x
23. L. Gan Y. Gan C. Zhu X. Zhang J. Zhu 2009 Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results Int. J. Pharm. 365 143 149 18773948 1:CAS:528:DC%2BD1cXhsVKnur7I 10.1016/j.ijpharm.2008.08.004
24. R. A. Ganz J. Viveiros A. Ahmad A. Ahmadi A. Khalil M. J. Tolkoff N. S. Nishioka M. R. Hamblin 2005 Helicobacter pylori in patients can be killed by visible light Lasers Surg. Med. 36 260 265 15791671 10.1002/lsm.20161 (Pubitemid 40578017)
25. S. George M. R. Hamblin A. Kishen 2009 Uptake pathways of anionic and cationic photosensitizers into bacteria Photochem. Photobiol. Sci. 8 788 795 19492106 1:CAS:528:DC%2BD1MXms1yitrs%3D 10.1039/b809624d
26. J. S. Giusti L. Santos-Pinto A. C. Pizzolito K. Helmerson E. Carvalho-Filho C. Kurachi V. S. Bagnato 2008 Antimicrobial photodynamic action on dentin using a lighte-mitting diode light source Photomed. Laser Surg. 26 281 287 18637719 10.1089/pho.2007.2149
27. M. R. Hamblin D. A. O'Donnell N. Murthy K. Rajagopalan N. Michaud M. E. Sherwood T. Hasan 2002 Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria J. Antimicrob. Chemother. 49 941 951 12039886 1:CAS:528:DC%2BD38XltVyrsbs%3D 10.1093/jac/dkf053 (Pubitemid 34692888)
28. M. R. Hamblin T. Hasan 2004 Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3 436 450 15122361 1:CAS:528:DC%2BD2cXjsFCiurg%3D 10.1039/b311900a (Pubitemid 38855151)
29. V. Hartmann S. Keipert 2000 Physico-chemical, in vitro and in vivo characterization of polymers for ocular use Pharmazie 55 440 443 10907252 1:CAS:528:DC%2BD3cXktlekurw%3D (Pubitemid 30415501)
30. E. E. Hassan J. M. Gallo 1990 A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength Pharm. Res. 7 491 495 1694990 1:CAS:528:DyaK3cXltVehtbk%3D 10.1023/A:1015812615635 (Pubitemid 20322199)
31. W. Hongcharu C. R. Taylor Y. Chang D. Aghassi K. Suthamjariya R. R. Anderson 2000 Topical ALAphotodynamic therapy for the treatment of acne vulgaris J. Invest. Dermatol. 115 183 192 10951234 1:CAS:528:DC%2BD3cXlvFOlt7o%3D 10.1046/j.1523-1747.2000.00046.x (Pubitemid 30637186)
32. L. Huang M. Terakawa T. Zhiyentayev Y. Y. Huang Y. Sawayama A. Jahnke G. P. Tegos T. Wharton M. R. Hamblin 2010 Innovative cationic fullerenes as broadspectrum light-activated antimicrobials Nanomedicine 6 442 452 19914400 1:CAS:528:DC%2BC3cXhtVyrsrbP 10.1016/j.nano.2009.10.005
33. S. Ishikawa K. Suzuki E. Fukuda K. Arihara Y. Yamamoto T. Mukai M. Itoh 2010 Photodynamic antimicrobial activity of avian eggshell pigments FEBS Lett. 584 770 774 20036664 1:CAS:528:DC%2BC3cXhs1yht7w%3D 10.1016/j.febslet.2009.12. 041
34. K. Jarvinen T. Jarvinen A. Urtti 1995 Ocular absorption following topical delivery Adv. Drug Deliv. Rev. 16 3 19 10.1016/0169-409X(95)00010-5
35. G. Jori C. Fabris M. Soncin S. Ferro O. Coppellotti D. Dei L. Fantetti G. Chiti G. Roncucci 2006 Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications Lasers Surg. Med. 38 468 481 16788934 10.1002/lsm.20361
36. M. A. Kalam Y. Sultana A. Samad A. Ali M. Aqil M. Sharma A. K. Mishra 2008 Gelrite-based in vitro gelation ophthalmic drug delivery system of gatifloxacin J. Dispers. Sci. Technol. 29 89 96 1:CAS:528:DC%2BD2sXhsVelsL3L 10.1080/01932690701688482
37. H.-J. Kao Y.-L. Lo W.-J. Vong Y.-J. Lin H.-R. Lin 2006 Treating allergic conjunctivitis using in situ polyelectrolyte gelling systems J. Biomater. Sci. Polym. Ed. 17 1191 1205 1:CAS:528:DC%2BD28Xht1yksrbE 10.1163/156856206778530740 (Pubitemid 44593443)
38. I. P. Kaur M. Singh M. Kanwar 2000 Formulation and evaluation of ophthalmic preparations of acetazolamide Int. J. Pharm. 199 119 127 10802405 1:CAS:528:DC%2BD3cXjtVWqsro%3D 10.1016/S0378-5173(00)00359-8 (Pubitemid 30236183)
39. I. P. Kaur A. Garg A. K. Singla D. Aggarwal 2004 Vesicular systems in ocular drug delivery: an overview Int. J. Pharm. 269 1 14 14698571 1:CAS:528:DC%2BD3sXpvFeks7k%3D 10.1016/j.ijpharm.2003.09.016 (Pubitemid 38035207)
40. D. H. Kim W. J. Stark T. P. O'Brien J. D. Dick 2005 Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients Ophthalmology 112 1992 1996 16183125 10.1016/j.ophtha.2005.06.017 (Pubitemid 41551929)
41. N. Kömerik H. Nakanishi A. J. MacRobert B. Henderson P. Speight M. Wilson 2003 In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model Antimicrob. Agents Chemother. 47 932 940 12604524 10.1128/AAC.47.3.932-940.2003 (Pubitemid 36254218)
42. W. Kubo S. Miyazaki D. Attwood 2003 Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations Int. J. Pharm. 258 55 64 12753753 1:CAS:528:DC%2BD3sXjsFyis74%3D 10.1016/S0378-5173(03) 00163-7 (Pubitemid 36712870)
43. S. A. Lambrechts T. N. Demidova M. C. Aalders T. Hasan M. R. Hamblin 2005 Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice Photochem. Photobiol. Sci. 4 503 509 15986057 1:CAS:528:DC%2BD2MXlsF2htbo%3D 10.1039/b502125a (Pubitemid 41044579)
44. M. H. Langlois M. Montagut J. P. Dubost J. Grellet M. C. Saux 2005 Protonation equilibrium and lipophilicity of moxifloxacin J. Pharm. Biomed. Anal. 37 389 393 15708683 1:CAS:528:DC%2BD2MXhtlSksr4%3D 10.1016/j.jpba.2004.10. 022 (Pubitemid 40222313)
45. K. Lasocki M. Szpakowska J. Grzybowski A. Graczyk 1999 Examination of antibacterial activity of the photoactivated arginine haematoporphyrin derivative Pharmacol. Res. 39 181 184 10094842 1:CAS:528:DyaK1MXisVyjsrs%3D 10.1006/phrs.1998.0431 (Pubitemid 29119022)
46. A. J. Lembo R. A. Ganz S. Sheth D. Cave C. Kelly P. Levin P. T. Kazlas P. C. Baldwin 3rd W. R. Lindmark J. R. McGrath M. R. Hamblin 2009 Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial Lasers Surg. Med. 41 337 344 19533762 10.1002/lsm.20770
47. J. M. Levine R. J. Noecker L. C. Lane L. Herrygers D. Nix R. W. Snyder 2004 Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing J. Cataract Refract. Surg. 30 2177 282 15474833 10.1016/j.jcrs.2004.06.048 (Pubitemid 39330678)
48. D. Q. Li Z. Chen X. J. Song L. Luo S. C. Pflugfelder 2004 Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells Invest. Ophthalmol. Vis. Sci. 45 4302 4311 15557436 10.1167/iovs.04-0299 (Pubitemid 39564654)
49. H. R. Lin K. C. Sung 2000 Carbopol/pluronic phase change solutions for ophthalmic drug delivery J. Control. Release 69 379 388 11102678 1:CAS:528:DC%2BD3cXotlart7s%3D 10.1016/S0168-3659(00)00329-1
50. A. Lipovsky Y. Nitzan H. Friedmann R. Lubart 2009 Sensitivity of Staphylococcus aureus strains to broadband visible light Photochem. Photobiol. 85 255 260 18764895 1:CAS:528:DC%2BD1MXislamsLY%3D 10.1111/j.1751-1097.2008. 00429.x
51. Y. Liu J. Liu X. Zhang R. Zhang Y. Huang C. Wu 2010 In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery AAPS PharmSciTech 11 610 620 20354916 10.1208/s12249-010-9413-0
52. Z. Liu J. Li S. Nie H. Liu P. Ding W. Pan 2006 Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin Int. J. Pharm. 315 12 17 16616442 1:CAS:528:DC%2BD28XksFyiu7o%3D 10.1016/j.ijpharm.2006.01.029 (Pubitemid 43674115)
53. A. Ludwig 2005 The use of mucoadhesive polymers in ocular drug delivery Adv. Drug Deliv. Rev. 57 1595 1639 16198021 1:CAS:528:DC%2BD2MXhtFSis7fF 10.1016/j.addr.2005.07.005 (Pubitemid 41443472)
54. L. Luo D. Q. Li R. M. Corrales S. C. Pflugfelder 2005 Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface Eye Contact Lens 31 186 193 16163009 10.1097/01.ICL.0000162759.79740.46 (Pubitemid 43197004)
55. W. D. Ma H. Xu C. Wang S. F. Nie W. S. Pan 2008 Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system Int. J. Pharm. 350 247 256 17961940 1:CAS:528: DC%2BD1cXhtlGntbY%3D 10.1016/j.ijpharm.2007.09.005 (Pubitemid 351146682)
56. M. Maclean S. J. MacGregor J. G. Anderson G. Woolsey 2009 Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array Appl. Environ. Microbiol. 75 1932 1937 19201962 1:CAS:528:DC%2BD1MXksFWltrw%3D 10.1128/AEM.01892-08
57. B. K. Nanjawade F. V. Manvi A. S. Manjappa 2007 In situ-forming hydrogels for sustained ophthalmic drug delivery J. Control. Release 122 119 134 17719120 1:CAS:528:DC%2BD2sXhtVSktbjO 10.1016/j.jconrel.2007.07.009 (Pubitemid 47361409)
58. J. Neupane S. Ghimire S. Shakya L. Chaudhary V. P. Shrivastava 2010 Effect of light emitting diodes in the photodynamic therapy of rheumatoid arthritis Photodiagnosis Photodyn. Ther. 7 44 49 20230993 10.1016/j.pdpdt.2009. 12.006
59. M. Nisnevitch F. Nakonechny Y. Nitzan 2010 Photodynamic antimicrobial chemotherapy by liposome-encapsulated water-soluble photosensitizers Russ. J. Bioorganic Chem. 36 363 369 1:CAS:528:DC%2BC3cXmslSkurc%3D 10.1134/ S106816201003012X
60. Y. Nitzan M. Salmon-Divon E. Shporen Z. Malik 2004 ALA induced photodynamic effects on gram positive and negative bacteria. Photochem Photobiol. Sci. 3 430 435 1:CAS:528:DC%2BD2cXjsFCiu70%3D 10.1039/b315633h (Pubitemid 38855150)
61. J. A. Ocaña F. J. Barragán M. Callejón 2000 Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum Analyst 125 2322 2325 11219075 10.1039/b005991i (Pubitemid 32015112)
62. G. S. Omar M. Wilson S. P. Nair 2008 Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light BMC Microbiol. 8 111 120 18593460 10.1186/1471-2180-8-111
63. K. O'Riordan O. E. Akilov T. Hasan 2005 The potential for photodynamic therapy in the treatment of localized infections Photodiagnosis Photodyn. Ther. 2 247 262 10.1016/S1572-1000(05)00099-2 (Pubitemid 43061343)
64. P. K. Pawar D. K. Majumdar 2006 Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas AAPS PharmSciTech 7 E13 16584143 10.1208/pt070113 (Pubitemid 43338077)
65. L. S. Peloi R. R. Soares C. E. Biondo V. R. Souza N. Hioka E. Kimura 2008 Photodynamic effect of light-emitting diode light on cell growth inhibition induced by methylene blue J. Biosci. 33 231 237 18535357 1:CAS:528: DC%2BD1cXotlGjtrs%3D 10.1007/s12038-008-0040-9 (Pubitemid 351840254)
66. H. Qi L. Li C. Huang W. Li C. Wu 2006 Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use Chem. Pharm. Bull. (Tokyo) 54 1500 1507 1:CAS:528: DC%2BD2sXjsFCnsw%3D%3D 10.1248/cpb.54.1500 (Pubitemid 44703975)
67. H. Qi W. Chen C. Huang L. Li C. Chen W. Li C. Wu 2007 Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin Int. J. Pharm. 337 178 187 17254725 1:CAS:528:DC%2BD2sXlsFagsrw%3D 10.1016/j.ijpharm.2006.12.038 (Pubitemid 46756045)
68. M. S. Rathore D. K. Majumdar 2006 Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops AAPS PharmSciTech 7 57 17025238 10.1208/pt070357 (Pubitemid 44081020)
69. T. M. A. Razek R. I. El-Baqary A. E. Ramadan 2008 Fluorimetric determination of gatifloxacin in aqueous, pure and pharmaceutical formulations Anal. Lett. 41 417 423 1:CAS:528:DC%2BD1cXhslOis7w%3D 10.1080/00032710701746816 (Pubitemid 351238320)
70. P. L. Ritger N. A. Peppas 1987 A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J. Control. Release 5 37 42 1:CAS:528:DyaL2sXkvVeku7s%3D 10.1016/0168-3659(87) 90035-6 (Pubitemid 17106644)
71. S. M. Robertson M. A. Curtis B. A. Schlech A. Rusinko G. R. Owen O. Dembinska J. Liao D. C. Dahlin 2005 Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans Surv. Ophthalmol. 50 Suppl1 S32 S45 16257309 10.1016/j.survophthal.2005.07.001 (Pubitemid 41657597)
72. S. Roy K. Pal A. Anis K. Pramanik B. Prabhakar 2009 Polymers in mucoadhesive drug delivery system: a brief note Des. Monomers Polym. 12 483 495 1:CAS:528:DC%2BD1MXhsVOhsrbE 10.1163/138577209X12478283327236
73. A. Rozier C. Mazuel J. Grove B. Plazonnet 1989 Gelrite®: a novel, ion-activated in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol Int. J. Pharm. 57 163 168 1:CAS:528: DyaK3cXhtVClurc%3D 10.1016/0378-5173(89)90305-0 (Pubitemid 20011840)
74. H. Salem 2005 Spectrofluorimetric, atomic absorption spectrometric and spectrophotometric determination of some fluoroquinolones Am. J. Appl. Sci. 2 719 729 1:CAS:528:DC%2BD2MXltVKrt7g%3D 10.3844/ajassp.2005.719.729
75. Y. D. Sanzgiri S. Maschi V. Crescenzi L. Calligaro E. M. Topp V. J. Stella 1993 Gellan-based systems for ophthalmic sustained delivery of methylprednisolone (MP) J. Control. Release 26 195 201 1:CAS:528: DyaK2cXhsVOgtg%3D%3D 10.1016/0168-3659(93)90186-9 (Pubitemid 23287364)
76. N. Schrage H. Wuestemeyer S. Langefeld 2004 Do different osmolar solutions change the epithelial surface of the healthy rabbit cornea? Graefes Arch. Clin. Exp. Ophthalmol. 242 668 673 15224214 1:CAS:528:DC%2BD2cXmvVOns70%3D 10.1007/s00417-004-0883-1 (Pubitemid 39242842)
77. D. Sensoy E. Cevher A. Sarici M. Yilmaz A. Ozdamar N. Bergisşadi 2009 Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model Eur. J. Pharm. Biopharm. 72 487 495 19223014 1:CAS:528:DC%2BD1MXnvVamsL0%3D 10.1016/j.ejpb.2009.02.006
78. W. M. Sharman C. M. Allen J. E. van Lier 1999 Photodynamic therapeutics: basic principles and clinical applications Drug Discov. Today 4 507 517 10529768 1:CAS:528:DyaK1MXmvVKhsrY%3D 10.1016/S1359-6446(99)01412-9 (Pubitemid 29497854)
79. B. Singh G. S. Chauhan D. K. Sharma N. Chauhan 2007 The release dynamics of salicylic acid and tetracycline hydrochloride from the psyllium and polyacrylamide based hydrogels (II) Carbohydr. Polym. 67 559 565 1:CAS:528:DC%2BD2sXotFeitg%3D%3D 10.1016/j.carbpol.2006.06.030 (Pubitemid 46097088)
80. R. Solomon E. D. Donnenfeld H. D. Perry R. W. Snyder C. Nedrud J. Stein A. Bloom 2005 Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor Ophthalmology 112 466 469 15745775 10.1016/j.ophtha.2004.09.029 (Pubitemid 40312502)
81. B. Srividya R. M. Cardoza P. D. Amin 2001 Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system J. Control. Release 73 205 211 11516498 1:CAS:528:DC%2BD3MXksVSqtbY%3D 10.1016/S0168-3659(01)00279-6 (Pubitemid 32539249)
82. U. Stahl M. D. Willcox T. Naduvilath F. Stapleton 2009 Influence of tear film and contact lens osmolality on ocular comfort in contact lens wear Optom. Vis. Sci. 86 857 867 19525883 10.1097/OPX.0b013e3181ae027b
83. D. W. Stroman J. J. Dajcs G. A. Cupp B. A. Schlech 2005 In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone Surv. Ophthalmol. 50 Suppl1 S16 S31 16257308 10.1016/j.survophthal.2005.06.002 (Pubitemid 41657596)
84. Y. Sultana M. Aqil A. Ali 2006 Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops Drug Deliv. 13 215 219 16556574 1:CAS:528:DC%2BD28XislCkurY%3D 10.1080/10717540500309164
85. M. C. Teichert J. W. Jones M. N. Usacheva M. A. Biel 2002 Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93 155 160 11862203 1:STN:280:DC%2BD387ms1ChsQ%3D%3D 10.1067/moe.2002. 120051 (Pubitemid 41115718)
86. G. Torkildsen T. P. O'Brien 2008 Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers Clin. Ther. 30 2005 2014 19108788 1:CAS:528: DC%2BD1MXhsV2gurY%3D 10.1016/j.clinthera.2008.10.020
87. A. Urtti 2006 Challenges and obstacles of ocular pharmacokinetics and drug delivery Adv. Drug Deliv. Rev. 58 1131 1135 17097758 1:CAS:528: DC%2BD28Xht1CnsL3M 10.1016/j.addr.2006.07.027
88. M. N. Usacheva M. C. Teichert M. A. Biel 2001 Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms Lasers Surg. Med. 29 165 173 11553906 1:STN:280:DC%2BD3Mrgt1Knuw%3D%3D 10.1002/lsm.1105 (Pubitemid 32808307)
89. T. F. Vandamme L. Brobeck 2005 Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide J. Control. Release 102 23 38 15653131 1:CAS:528:DC%2BD2MXktVGjsQ%3D%3D 10.1016/j.jconrel. 2004.09.015 (Pubitemid 40093773)
90. G. Wei H. Xu P. T. Ding S. M. Li J. M. Zheng 2002 Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies J. Control. Release 83 65 74 12220839 1:CAS:528: DC%2BD38XmslKqtrw%3D 10.1016/S0168-3659(02)00175-X (Pubitemid 35239815)
91. W. Weyenberg A. Vermeire M. M. Dhondt E. Adriaens P. Kestelyn J. P. Remon A. Ludwig 2004 Ocular bioerodible minitablets as strategy for the management of microbial keratitis Invest. Ophthalmol. Vis. Sci. 45 3229 3233 15326145 10.1167/iovs.04-0206 (Pubitemid 39121860)
92. S. R. Wiegell H. C. Wulf 2006 Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial Br. J. Dermatol. 154 969 976 16634903 1:CAS:528:DC%2BD28Xls1Crs74%3D 10.1111/j.1365-2133.2005.07107.x
93. T. W. Wong Y. Y. Wang H. M. Sheu Y. C. Chuang 2005 Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus Antimicrob. Agents Chemother. 49 895 902 15728881 1:CAS:528:DC%2BD2MXit12mtL4%3D 10.1128/AAC.49.3.895-902.2005 (Pubitemid 40327702)
94. C. Wu H. Qi W. Chen C. Huang C. Su W. Li S. Hou 2007 Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin Yakugaku Zasshi 127 183 191 17202799 1:CAS:528:DC%2BD2sXktVSltrw%3D 10.1248/yakushi.127.183 (Pubitemid 46089916)
95. K. C. Yoon K. Y. Ahn S. E. Lee K. K. Kim S. K. Im H. J. Oh I. Y. Jeong S. W. Park Y. G. Park H. J. Nah W. B. Im 2006 Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin Curr. Eye Res. 31 215 224 16531278 1:CAS:528:DC%2BD28XisVaqsbg%3D 10.1080/02713680600559564 (Pubitemid 43379191)
96. B. Zeina J. Greenman W. M. Purcell B. Das 2001 Killing of cutaneous microbial species by photodynamic therapy Br. J. Dermatol. 144 274 278 11251558 1:STN:280:DC%2BD3M3jsVyqtw%3D%3D 10.1046/j.1365-2133.2001.04013.x (Pubitemid 32178805)
97. P. S. Zolfaghari S. Packer M. Singer S. P. Nair J. Bennett C. Street M. Wilson 2009 In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent BMC Microbiol. 9 27 19193212 10.1186/1471-2180-9-27